Allen & Overy LLP provides full-service assistance in the healthcare and life sciences space, covering M&A, finance, regulatory, disputes and data protection mandates. The team deals with leading pharmaceutical, generics, biotech and med-tech companies, as well as investors and universities. Corporate and M&A lawyer Christiaan De Brauw is the trusted counsel for many leading biotech companies, dealing with start-ups, IPOs and takeovers. Frits Gerritzen is a specialist IP litigator, working on patent cases in the field of medical equipment, pharmaceuticals and antibodies. He also supports clients on R&D agreements and technical collaborations in which IP plays a key role. Ellen Cramer-De Jong heads the investment management team, focusing on investment firms providing financing for healthcare and life sciences companies and deals with ESG and emerging markets matters in the life sciences area.
Industry focus: healthcare and life sciences in Netherlands
Allen & Overy LLP
Frits Gerritzen; Christiaan de Brauw; Ellen Cramer-De Jong
‘Great industry knowledge, available and pragmatic.’
‘Christiaan De Brauw has invaluable experience and is brilliant in navigating legal complexities.’
‘The due diligence proceeded extremely smoothly.’
LSP / Life Sciences Parters
Hogan Lovells International LLP‘s Dutch healthcare and life sciences practice leverages its international presence and collaborations with other offices in order to advise global clients on global regulatory surveillance issues. Regulatory specialist Hein van den Bos and patent expert Bert Oosting assists global pharmaceutical companies with patent enforcements of innovative products and regulatory advice, including pricing, reimbursement and tendering issues. The experienced Ruud van der Velden represents companies in high-tech and life sciences industries in multi-jurisdiction patent and trade secret litigation and Joke Bodewits resolves compliance and enforcement issues, dealing with cybersecurity incidents and international data transfers. He also drafts commercial contracts, including IT licensing agreements and distribution agreements. Senior associate Chantal Van Dam supports Bodewits on global data protection strategies. Senior associate Karen Jelsma and recently promoted counsel Dirk-Jan Ridderinkhof add further depth and dimension to the practice, with the former focusing on product liability matters in the life sciences area, and the latter a key patent litigation contact. The team also supports global biotech companies with Dutch market entry strategies. Gertjan Kuipers was a new arrival in April 2023 from De Brauw Blackstone Westbroek.
Hein van den Bos; Bert Oosting; Joke Bodewits
Other key lawyers:
Karen Jelsma; Dirk-Jan Ridderinkhof; Chantal van Dam; Gertjan Kuipers
‘Deep and extensive knowledge of the sector’
‘Broad scope of services in terms of international presence and contacts as well as expertise in Life Sciences sector through different areas of law’
‘Hein van den Bos is very pleasant to work with’
Loyens & Loeff is ‘well equipped to handle healthcare and health insurance matters’, with a particular skill in combining legal and tax knowledge when advising local care providers and global pharmaceutical companies. The team also frequently advises clients on competition law and the governance aspects of partnerships in the healthcare industry, concerning individual care providers or the joint purchasing of medicines by hospitals and healthcare insurers. Tom van Helmond focuses on regulatory, litigation and competition work and Kim Lucassen specialises in contracts and data protection in both the healthcare and life sciences areas. New York-based Vincent van der Lans is strategically placed to assist multinational life sciences corporations and investment firms with international tax matters. Marc Wiggers is sought out by healthcare insurers and providers for contentious and non-contentious assistance. At associate level, Dieuwke Hooft Graafland, who is an expert in regulatory law and represents clients in insurance and financing disputes; data protection and privacy law specialist Céline Van Waesberge, who works for clients in the pharmaceutical, medical devices and DNA sequencing fields; and Aurélie Mingels, who provides clients with purchasing strategies and advises on tender procedures, are the names to note.
Tom van Helmond; Kim Lucassen; Vincent van der Lans
Other key lawyers:
Marc Wiggers; Dieuwke Hooft Graafland; Céline van Waesberge; Aurélie Mingels
‘Knowledgeable of the rules, good factual research and knowledge of the market – one of the few firms that are well equipped to handle healthcare and health insurance matters’
‘Tom van Helmond leads a team of aspiring young lawyers and manages the team professionally’
‘Aware of the most current developments; excellent file knowledge; able to think strategically and point out opportunities and threats.’
‘Knowledgeable, accessible, short response time, able to make complex matters simple’
‘The team works together and has the relevant knowledge and experience to be able to answer various topics.’
‘Aurelie Mingels: involved, experienced, approachable and friendly’
European Investment Bank
Zilveren Kruis Zorgverzekeringen N.V.
Becton Dickson and Company
- Advised Solvias AG, one of the world’s leading independent pharmaceutical testing and manufacturing companies, on the acquisition of Netherlands-based Cergentis.
- Assisted EQT in the acquisition of Life Sciences Partners (LSP).
- Advised Zorgverzekeraars Nederland (ZN) with respect to the provision of contributions to healthcare providers in order to ‘survive’ the covid-19 crisis.
NautaDutilh’s healthcare and life sciences team is ‘pragmatic to work with and focused on optimising the best commercial deal’ and acts for high-profile clients on the full scope of work. Ruud Smits acts for biotech, med-tech and pharmaceutical companies on corporate mandates, including financing strategies and M&A and IP specialist Anne Marie Verschuur represents international biopharmaceutical companies in global patent and trademark disputes. Recently promoted partner Jeroen Boelens works alongside Verschuur in complex IP matters. Stijn Franken focuses on disputes concerning product liability; Wijnand Bossenbroek‘s work covers corporate, and financing advice for pharmaceutical companies; Petra Zijp and Paul van der Bijl specialise in cross-border equity capital market transactions and debt offerings with listings on Euronext Amsterdam and abroad. New York-based Rebecca Pinto strengthens the firm’s global relationships and adds an extra dimension to the scope of the practice – dealing with private equity mandates in the life sciences and technology sectors. Sybren de Beur further strengthens the team's corporate expertise in the life sciences space.
Ruud Smits; Anne Marie Verschuur
Other key lawyers:
Stijn Franken; Wijnand Bossenbroek; Petra Zijp; Paul van der Bijl; Rebecca Pinto; Sybren de Beurs; Jeroen Boelens; Joppe Schoute; Jeanine Evertse
‘High level of responsiveness and good understanding of the dynamics, in particular in an m&a context.
‘Reliability and friendliness in the collaboration.’
‘Most experienced team in Benelux – pragmatic to work with and focused on optimizing the best commercial deal.’
‘Nauta-Dutilh is a great practice with a great supportive team for companies with a Dutch presence. They are a rare group that actually tries to understand what is needed and what is asked and to do it in the best, simplest way possible. They provide good, realistic and pragmatic legal advice.’
‘Ruud Smits is an amazing legal advisor. He is the most pragmatic lawyer I have had a chance to work with. A true legal partner. The rest of the team is also very reliable, responsive and helpful.’
Ginkgo Bioworks, Inc.
Johnson & Johnson
Levine Leichtman Capital
LUMICKS Technologies B.V.
Novo Holdings A/S
NorthSea Therapeutics B.V.
NewAmsterdam Pharma B.V.
Olympus Winter & Ibe GmbH
Aseptix Health Sciences
Pharming Group N.V.
- Assisted Sanofi with its recommended all-cash public offer on all issued and outstanding shares of Kiadis Pharma.
- Defending GlaxoSmithKline in appeal proceedings regarding a product liability claim.
- Advises NewAmsterdam Pharma on its USD 470 million business combination with Frazier Lifesciences Acquisition Corp, alongside Covington & Burling.
Amsterdam-based healthcare specialist Joris Rijken and Eindhoven-based life sciences practitioner Barbara Mutsaers lead AKD’s healthcare and life sciences practice. Rijken assists healthcare advisers with care procurements and contracts with various government bodies and provides regulatory advice on medical scientific research. Mutsaers frequently deals with sector specific regulations, including market access and compliance regarding the prohibition of inducements and clinical trials; she also handles various agreements, namely R&D and license agreements. The team frequently works on entry strategies for foreign clients in the life sciences sector.
Other key lawyers:
Barbara Mutsaers; Maartje de Jong
‘The team has knowledge on a braod area of healthcare and health insurance, acting on behalf of serious players in the field, particularly healthcare institutions’
‘If I need to highlight one of the legal partners, I must mention Barbara Mutsaers. As an entrepreneur, I choose Barbara Mutsaers because she goes the extra mile and is not only a legal partner but also a co-worker.’
‘The team is highly knowledgeable within the health care industry and very well connected to relevant authorities and utilises their connections to improve the quality of their counselling.’
‘High level of analytical thinking and focus on problem solving. The team is very pragmatic and always work with a smile.’
‘For us the team has been centered around Barbara Mutsaers. Our interaction with the team has been very satisfactory because of her.’
‘We do work primarily with Barbara Mutsaers, who has proven to be an outstanding professional. She has been available 24/7, always ready to do the extra effort. She has been able to get to the core of the matter immediately and digests much information rapidly to offer us immediate and very tangible advice. She is very knowledgeable in the Healthcare sector and has outsmarted opposing lawyers in many instances. Her communication style has been sharp, coherent and respectful.’
‘Joris Rijken is dedicated, involved in our care operations, ‘speaks the language’, can relate to our business and is a quick thinker.’
‘Barbara Mutsaers is an exceptional lawyer. What make her stand-out from other lawyers is that she combines her strong expertise in the legislation area with an in-depth understanding of the business needs in the life sciences space.’
Stichting Zuyderland Medisch Centrum
Prinses Máxima Centrum voor Kinderoncologie B.V.
Reinier Haga Groep
Dutch Association for Care for People with a Handicap
Dutch Association of Mental Health and Addiction Care
Erasmus Medical Center
Alliance Healthcare Nederland B.V.
Biomet 3i Netherlands B.V./Zimmer Dental Inc.
Hestia Cardiovascular Service Center B.V.
Eurocom Healthcare Technology B.V.
Merz Pharma Benelux B.V.
Vaxxinova International B.V.
- Advising Stichting Reinier Haga Groep on a demerge
- Assisting the mental care provider HSK in a successful appeal against a fine by the Dutch Healthcare Authority
- Advising Nafinco, a buying group for more than 200 pharmacies, on an investment by Freshstream, a British investment firm
BarentsKrans’ multi-disciplinary industry-focused healthcare and life sciences practice deals with the whole chain of life sciences mandates, ranging from disputes concerning regulation and patents for the entry of pharmaceutical products to clinical trial agreements and product liability. Healthcare specialist Tim Raats focuses on competition and procurement law, advising hospitals on merger control issues and obtaining clearances; he also advises mental health providers on municipal tendering. The team, including IP and technology specialist Jaap Bremer, deals with contracts pertaining to medical devices and the launch of biosimilar products. In February 2023, former practice head Marleen van den Horst left for La Gro Geelkerken Advocaten.
Other key lawyers:
Tim Raats; Jaap Bremer
‘Jaap is very knowledgeable, not only from a legal perspective, but also from a sector perspective. It cannot be stressed enough that this does make the difference. He thinks in solutions, not problems.’
‘Jaap Bremer is always a pleasure to work with. Responses are swift and correct. Time is efficiently used and solutions are provided.’
‘Jaap Bremer is extremely active in the life sciences sector. It is a focus for the firm.’
‘Jaap Bremer is an exceptional lawyer with a deep knowledge of the life sciences sector.’
‘Jaap Bremer runs a small but dedicated team. Jaap is a creative patent litigator.’
Stichting Haaglanden Medisch Centrum
NeoKidney Foundation and Dutch Kidney Foundation
AET (Alfred E. Tiefenbacher)
Focus Care Pharmaceuticals
Stada Arzneimittel / Centrafarm
Medisch Specialisten Collectief RdGG UA
Advance Medical Designs
- Successfully represented Insud Pharma in final relief invalidity proceedings against the Dutch part of EP 3 102 187 B1, held by Galenicum, regarding sitagliptin.
- Acting as trusted counsel for HMC, the largest hospital in The Hague region, in all legal matters.
- Representing Viatris (Mylan) in ground-breaking multijurisdictional patent litigation initiated by Novartis with respect to fingolimod, an immunosuppressant drug used for treatment of multiple sclerosis.
Bird & Bird‘s healthcare and life sciences practice is known for its IP focus, with practitioners ‘very strong in chemical and pharmaceutical patent matters (including regulatory issues)’. Hague-based Marc van Wijngaarden co-heads the Dutch life sciences group, specialising in patent litigation, compliance, corporate and competition laws for pharmaceutical, biotech and medical devices companies. Fellow co-head Michiel Wurfbain advises on cross-border M&A deals, public-to-private transactions, financial matters and corporate governance. Armand Killan is an expert in patent disputes involving medical devices and pharmaceutical clients. Amsterdam-based Wouter Pors focuses on complex contentious matters concerning regulatory issues and IP disputes with an EU-wide dimension. Competition & EU Law expert Janneke Kohlen assists clients with public procurement, merger control, cartel cases and abuse of dominance matters. Patent and trade secret issues are the main focus of Tjibbe Douma's practice. Counsel Peter Van Gemert and associate Hester Borgers are key patent litigation and regulatory specialists in the team.
Marc van Wijngaarden; Michiel Wurfbain
Other key lawyers:
Armand Killan; Wouter Pors; Janneke Kohlen; Tjibbe Douma; Peter van Gemert; Hester Borgers
‘Bird & Bird the Netherlands, is unique as it has a strong and experienced focus on IP, in particular patents.’
‘The partners in the IP department have specialized in different technique groups and are very strong in chemical and pharmaceutical patent matters (including regulatory issues). They take time and effort to understand and argue complex or unique pharmaceutical cases in collaboration and guided by patent attorneys.’
‘Tjibbe Douma is unique in understanding complex chemical/pharmaceutical cases and is active in discussions concerning finding strategies’
‘The team has an outstanding technical knowledge combined with perfect control of legal questions. This allows them to provide strategic advice which fully suits the client’s needs and the situation.’
‘The team is very thorough and critical when reviewing both their own work and the work of collaboration partners, resulting in outstanding quality of all work in which they are involved.’
‘Tjibbe Douma is calm, firm, and highly intelligent. He asks the right questions at the right moments and does not shy away from productive critical discussions. He understands quickly and assesses thoroughly.’
‘Hester Borges has an outstanding capability to connect to the people she works with and understand their needs. At the same time, she always knows what the key points of the situation are and makes sure everyone is on the same page. She is very bright.’
B Braun Melsungen
Bilthoven Biologicals / Serum Institute of India
Stichting Katholieke Universiteit
- Represening Ablynx and the Vrije Universiteit Brussel (Brussels Free University, VUB) in a patent litigation case on basic patents for camelid antibodies against Unilever, VHsquared, QVQ and other potential defendants.
- Representing Ferring Pharmaceuticals in an ongoing patent cases in the Netherlands – a long-running dispute against Serentiy/Avadel.
- Representing Edwards Lifesciences in a multi-jurisdictional multi-patent dispute against Meril Life Sciences and its national distributor, in the light of Meril’s global launch of its prosthetic heart valve Myval.
CMS leverages its global life sciences group in order to provide clients with practical and commercial solutions. The team works on contentious and non-contentious mandates, representing healthcare companies in IP infringement cases and assisting biotech companies with incorporation and IPOs. Regulatory practice head Ellen Gielen advises international life sciences companies on a range of product issues including manufacturing and distribution, pricing and reimbursement, and advertising. Gertie Lintjens brings further industry-specific experience, assisting with business models and R&D projects.
Ellen Gielen; Gertie Lintjens
Other key lawyers:
Brocacef (a company of Phoenix group)
Johnson & Johnson
- Advised Johnson & Johnson on a winning landmark procedure regarding a product infringement by Fengh Medical
- Advised Mainz Biomed N.V. on its incorporation and listing at the Nasdaq Capital Market
- Advising Thermo Fisher on a multi-jurisdictional legal proceeding
De Brauw Blackstone Westbroek‘s healthcare and life sciences practice covers a wide range of matters for clients including global pharmaceutical and biotech companies, health clinics and investors. Tobias Cohen Jehoram is sought out for expertise in Supreme Court patent litigation, dealing with landmark IP decisions in the life sciences field. Reinier Kleipool is the key contact for listed companies and large multinationals, who require advise on M&A, corporate governance, investments and anti-takeover responses. Lennard Keijzer specialises in complex private equity issues, including assisting specialist healthcare investment firms in investments and divestments in the health sector. Associate Bertrand ter Woort adds depth to the patent litigation practice. Since research concluded, Gertjan Kuipers and Carlos van Staveren left the firm.
Tobias Cohen Jehoram; Reinier Kleipool; Lennard Keijzer
Other key lawyers:
Bertrand ter Woort
‘Dedicated and always available.’
Paine Schwarz Partners
- Advised Triton on investment in Bergman Clinics, a leading chain of independent clinics in the Netherlands, Germany and Scandinavia.
- Representing Advanced Bionics, part of the Sonova group, in multi-jurisdictional complex patent proceedings against Med-El relating to a patent for cochlear implant systems.
- Assisting the US-based biotechnology company Illumina with its acquisition of the pharmaceutical start-up GRAIL.
Houthoff‘s strength in the healthcare space is evident in its advice to providers, including hospitals and private clinics, on a full range of mandates. Weyer VerLoren van Themaat handles high-profile and complex mergers involving large private health clinics, which require extensive regulatory knowledge. Litigator Huib Lebbing frequently undertakes cases concerning contractual liability within the healthcare sector, where he acts as defence counsel. Freeke Heijne focuses on healthcare laws and regulation compliance. EU and competition law specialist Greetje van Heezik assists clients with regulations concerning both medicinal products and medical devices. Senior associate Murat Duman advises clients on investigations by the Dutch competition authority and the Dutch healthcare authority as well as merger control proceedings before such authorities. The team also advises investment companies on investments in healthcare companies.
Weyer VerLoren van Themaat; Huib Lebbing
Other key lawyers:
Freeke Heijne; Greetje van Heezik; Murat Duman
Leger des Heils
First Dutch Innovations
PlusDental / Sunshine Smile
Frazier Lifesciences Acquisition Corporation
- Representing Radbound UMC Hospital and its PI insurer Achmea in ongoing litigation concerning liability of medical practitioners and hospitals for use of defective medical implants.
- Assist Bea Zorg on various legal proceedings against the largest healthcare insurer in the Netherlands, Zilveren Kruis
- Advised FMS on a report prepared concerning the possibility of ending the independent status of medical specialists who work in hospitals without a labour agreement.
Simmons & Simmons
Advising global pharmaceutical companies on patent strategies concerning the enforcement and defence of infringement claims is at the core of Simmons & Simmons‘ healthcare and life sciences practice. Johan Renes deals with international patent litigation in various courts, involving disputes concerning small molecules, proteins and medical devices. He also guides companies through the life cycle of matters from inception to licensing and financing. Head of the IP practice Bas Berghuis Van Woortman focuses on patent disputes regarding medical devices, biotech, pharmaceuticals and software. Van Woortman also negotiates R&D agreements and works on issues relating to trade secrets. Patent litigator Oscar Lamme works on cross-jurisdictional cases where patent and competition law converge. The healthcare and life sciences practice has grown with the arrival of three business cycle experts from Nysingh advocaten-notarissen– Ekram Belhadj, Cees Dekker and Guido Fazzi – and patent attorney Xingye Huang.
Johan Renes; Bas Berghuis van Woortman
Other key lawyers:
Oscar Lamme; Ekram Belhadj; Cees Dekker; Guido Fazzi; Xingye Huang
Netherlands Cancer Institute
Seattle Genetics Inc.
Médecins sans frontiers
- Advising Samsung Bioepsis on EU market regulations and patent proceedings, for example, revocation and infringement proceedings against biosimilars competitor Fresenius.
- Represented Bayer Healthcare in patent proceedings against multiple parties for its synthetic chemistry, dosage form and formulation.
- Advising uniQure on all IP issues ranging from IPR proceedings to partnering and the acquisition of pipeline products and other assets.
Van Doorne’s multi-disciplinary healthcare and life sciences team handles traditional regulatory and litigation matters in the pharmaceutical arena and data protection and IT in the digital health-tech space for domestic and international clients. Healthcare law expert Willemien Bischot supports hospitals and healthcare providers with matters relating to the elderly and special needs space in complying with regulations. Bischot is entrusted with a full range of mandates, including financing, corporate governance and M&A. Life sciences specialist Dimitri van Hoewijk advises private equity firms, suppliers and manufacturers of medicinal products, start-ups and medical devices companies on M&A. Counsel Louis Jonker assists clients in the healthcare industry with IT and outsourcing projects. Healthcare providers entrust Steven Sterk with employment law matters, including reorganisations and dismissals. Corporate law focused duo Nick Suurmond and Siego Boslooper and tax lawyer Danielle Westerhoff are key supporting associates.
‘Expert, fast and always willing to get in touch to find a solution for complex issues.’
‘Skilled in translating complex legal issues quickly and adequately in clear language for us as a client.’
‘The various specializations make a unique blend. I never have to ask for specific expertise or knowledge, they are available without asking.’
‘Most lawyers at Van Doorne do not use ‘lawyer speak’ when discussing a case; there is always a ‘human touch’ and soft skills which makes it nice for opposing parties to have a conversation with them.’
‘Van Doorne has in-depth knowledge about the health sector, competent staff, prompt in scheduling appointments and has authority’
‘Willemien Bischot has played a crucial role in a difficult negotiation about the transfer of one of our units to another organisation.’
‘They have an inner circle healthcare team that closely cooperates with dedicated lawyers from all practice groups. It is never necessary to explain to them what is relevant for health care institutions. They are smart, clever, knowledgeable and deliver.’
‘Willemien Bischot is the prominent lawyer of the health care practice. Easy to reach, very hands on, knows all the relevant people and institutions, very smart, a top lawyer and an ideal account manager.’
Academisch Medisch Centrum
NKI – AVL
‘s Heeren Loo
VU Medisch Centrum
- Advised VieCuri Medisch Centrum and Laurentius Ziekenhuis on all legal aspects of a joint effort to keep emergency care available 24/7 in their region.
- Advised long-term care providers InteraktContour Groep and Stichting Boogh on their merger with a larger competitor.
- Continued to advise the two academic hospitals in Amsterdam, VUmc and AMC, on their collaboration and merger.
The litigation-focused life sciences practice at Vondst Advocaten N.V is regularly called upon by major pharmaceutical and medical devices companies. Otto Swens is the key name for patent and regulatory disputes, as well as pricing, parallel imports, reimbursements and product liability issues. Patent litigators Ricardo Dijkstra and Arvid Van Oorschot are also noted.
Otto Swens; Ricardo Dijkstra; Arvid van Oorschot
Other key lawyers:
Carly van der Beek
Sun Pharmaceuticals Industries
- Representing Glenmark Pharmaceuticals in patent litigation proceedings.
- Representing Vaselife in various regulatory proceedings before the administrative body concerning parallel trade permits for growth stimulators.
- Representing Curium Pharma in a dispute with one of its suppliers
Jointly led by healthcare expert Fenna van Dijk and life sciences specialist Maarten Schut, Kennedy Van der Laan's team handles the full breadth of mandates across the healthcare and life sciences segments. Combining a corporate background with a focus on healthcare, Van Dijk advises on market entry, licenses, clinical research, PPPs and drafting contracts with medical devices companies; she played a key role in the vaccine strategy concerning the Covid-19 pandemic. IP expert Schut advises multinational companies including Nutreco and Syngenta and not-for-profit institutions on conflicts relating to R&D and licensing. With the addition of Joran Spauwen, the practice has gained a specialist in IP-focused transactions in the advanced technologies sector, assisting healthcare service providers with medical devices regulation and negotiating contracts with AI suppliers. He also links the M&A practice to the healthcare and life sciences practice, focusing on innovative companies investing in the health tech industry. Counsel Sophie Van Loon specialises in contract drafting, advisory work and litigation within the life sciences field and associate Eline Lam focuses on corporate, healthcare and regulatory law.
Fenna van Dijk; Maarten Schut; Joran Spauwen
Other key lawyers:
Sophie van Loon; Eline Lam
‘The firm has a good life sciences non-contentious practice with good support for the intellectual property aspects of transactions.’
‘Maarten Schut is easy to deal with and good at focusing on the key issues.’
‘The webinars on new legislation and dilemmas are extremely informative and easy to follow for laymen and legal experts.’
‘The team consists of outstanding lawyers with a practical approach. The firm is our trusted partner for all sorts of health-related legal issues.’
‘Experts in tender management’
‘The professionality of Kennedy van der Laan is very high, the adequacy and speed in their answers suits my demands’
‘Good and nice working relationship with M. Schut. Very knowledgeable, has the ability to see the whole picture and at the same time see the devil in the detail. Good communication and negotiation skills, very nice to work with.’
‘Fenna van Dijk and Eline Lam are not only very involved, but also accurate and reliable and think ahead in solving problems. They see not only the legal obstacles, but also the solutions and possibilities.’
Arts en Zorg
Home Instead AG
- Advised the national association of public healthcare organisations devices on the implementation of the nation-wide Covid-19 vaccination strategy.
- Assisted renowned vaccine institute Intravacc in its privatization process and in cross-border negotiations on research co-operations regarding a COVID-19 vaccine.
- Advised LHV, the national association for general practitioners, on a revision of the manner in which it was organised, including its governance.
Maverick Advocaten N.V. is known for its competition law and litigation work concerning regulatory issues in the healthcare sector. A ‘To-the-point adviser who understands the complexity of decision-making processes within healthcare organisations’, Martijn Van De Hel advises healthcare organisations on the competition law aspects of setting up a cooperation and represents healthcare organisations in the approval proceedings at the NZA and ACM in case of a merger, takeover or the creation of a joint venture. With ‘overwhelming knowledge of the healthcare business’, Diederik Schrijvershof is sought out by both healthcare and pharmaceutical sector companies for advice on competition law and regulation.
Diederik Schrijvershof; Martijn van de Hel
‘They have knowledge of the current state of affairs and all decisions and publications leading to it in the field of regulatory. When discussing a case they also know right there how to approach the issue. Strong strategy; anticipate what is coming next.’
‘Diederik Schrijvershof has overwhelming knowledge of the healthcare business. Fast thinker, strategically strong. Martijn van de Hel is thorough’
‘Great, accessible, and very knowledgeable team regarding state aid law.’
‘Very focussed and experienced team of anti-trust lawyers. Accessible and proactive. Value for money. Very much into the healthcare sector.’
‘Martijn van de Hel is a to-the-point advisor who understands the complexity of decision-making processes within healthcare organisations. Not afraid to voice his opinion and to provide clients with practical advice.’
‘When it comes to competition law I prefer working with Maverick. They are approachable specialists, creative, quick, to the point and understand what the client needs. Maverick thinks about what is possible and not what is impossible and for that they really distinguish themselves from other law firms.’
‘Martijn van de Hel is a true strategic partner. He is approachable, gives hands-on advice and has a lot of adequate knowledge. He dares to think in possibilities and search for loopholes.’
De Nederlandse GGZ
Gilde Healthcare Partners B.V.
- Assisting Erasmus MC with obtaining second phase merger clearance from the Dutch Competition Authority (ACM) in the proposed merger, Erasmus MC/IJsselland.
- Assisting Mediq, a leading international supplier of medical products and healthcare solutions and part of Advent, to obtain second phase merger clearance from the ACM for the acquisition of Eurocept.
- Obtaining a victory against the NZa at the highest administrative court (CBb) for Arkin, a large mental healthcare provider, by obtaining cost covering funding for acute mental healthcare.
Representing public sector bodies in disputes is a key strength of The Hague-based Pels Rijcken & Droogleever Fortuijn NV‘s healthcare team. Elisabeth Pietermaat leads the public sector team, representing the Dutch Healthcare Authority and national regulatory authorities on issues related to the financing and macro-financing of healthcare. Experienced litigator Wemmeke Wisman acts for public sector clients in disputes involving the quality of healthcare and medicines – working on cases intersecting public and private law. Marije Batting heads the administrative law department, focusing on quality of care in the life sciences field, namely working on the approval of medicines, pricing and reimbursements. Associate Jorrit van de Weide represents public authorities and semi-public organisations on bankruptcies and continuities of healthcare providers. Associate Anna van Gijssel acts for municipalities in proceedings concerning the fraud in the healthcare space. The team also works with Dutch healthcare insurance companies.
Wemmeke Wisman; Marije Batting; Elisabeth Pietermaat
Other key lawyers:
Jorrit van de Weide; Anna van Gijssel
‘What makes Pels Rijcken stand out from other law firms is their punctuality, accuracy, accessibility, and their ability to meet every deadline. Also, the fact that they are State Advocates. I like working with them because they showed many times that they know what they are doing, they are always very well prepared and are all very knowledgeable.’
‘I work with Marije Batting and Maaike Feenstra. They are both skilled professionals, who chose to communicate in a very transparent way. Both Marije and Maaike are very punctual, meet their deadlines and are approachable. I find our cooperation going in a very nice way. I wouldn’t choose for any other lawyers.’
‘They have in-depth knowledge of the Dutch healthcare-system and they know how to act in the complex political and administrative environment.’
‘Wemmeke Wisman is extremely good at her job. She is a positive and pleasant person to work with. She is cooperative and takes into consideration the needs and opinions of the client. As a State Advocate, Wemmeke perfectly knows the working of a government and how to handle the political stakes. Therefore, she always knows exactly what to do, and which questions are the ones to ask before taking the right steps.’
‘Pels Rijcken is the State Advocate. Every lawyer knows how the government works. They are excellent at understanding and getting a sense of the political interests. This gives them the ability to give the right advice.’
‘Elisabeth Pietermaat is a very experienced and sharp lawyer who very well knows how the government works and the political interests at stake. It makes it very easy and trustworthy to work with.’
‘Pels Rijcken is a State Advocate. This makes them very unique. It ensures that we, as a client, only ask them for help if we have judicial procedures. Pels Rijcken’s lawyers are excellent litigators. They take you through every step of the process and make sure to offer you all the existing possibilities and discuss the pros and cons so we can evaluate the most suitable approach. I also find it very important and appreciate that they aren’t only great advisors and litigators, but they are also very good at teaching and giving different trainings within our company.’
‘Marije Batting is very good at what she is doing. She is always up to date on legal developments and understands things not only in a strategic but also in a political way. Marije is very good at evaluating situations in a very critical/accurate manner. She is very approachable and always available. She always makes sure her clients receive the needed help and support and also provides the best outcomes possible.’
Nederlandse Zorgautoriteit (NZa)
The State of the Netherlands (Ministry of Health, Welfare and Sport)
The State of the Netherlands (Ministry of Defence)
- Acting for Dutch Helathcare Authority, Nederlandse Zorgautoriteit (NZa), in a dispute over the setting of new tariffs for geriatric rehabilitation care for 2021.
- Represents the Minister of Health, Welfare and Sport in proceedings regarding a large contract for detecting Covid-19-infections using breath analysis.
- Rrepresents SDKB in civil proceedings initiated by a number of donor children to obtain the information of their (anonymous) sperm donors.
Pinsent Masons LLP
Following the launch of its Amsterdam office in February 2021, Pinsent Masons LLP has established itself as a key destination for clients in the healthcare and life sciences sector. With the arrival of Judith Krens in 2022 from Taylor Wessing, the team is headed by a vastly experienced and knowledgeable life sciences specialist. Krens focuses on cross-border patent and SPC litigation in the field of pharmaceuticals, biotech and medical devices. Andras Kupecz represents clients in patent cases regarding biosimilars and small molecule pharmaceuticals on a pan-European basis. The arrival of Machteld Hiemstra from Simmons & Simmons bolsters the team’s litigation experience; she handles global pharmaceutical-related product liability matters.
Other key lawyers:
Andras Kupecz; Machteld Hiemstra